NCT05510596
- Conditions
- Chemically-Induced Disorders, Cytokine Release Syndrome, Hemic and Lymphatic Diseases, +18 more
- Locations
-
- Neurology department, Montpellier University Hospital Montpellier, Occitanie, France
Clinical trial condition
Neurotoxicity
Explore clinical trials studying Neurotoxicity. Study availability and eligibility vary by location and protocol.
55 public trials
2 recruiting studies
Neurotoxicity trial results
NCT05094154
- Conditions
- AKI, Chemically-Induced Disorders, Infections, +9 more
- Locations
-
- Vanderbilt University Medical Center Nashville, Tennessee, United States
NCT01399372
- Conditions
- Chemically-Induced Disorders, Chemotherapeutic Agent Toxicity, Cognitive/Functional Effects, +15 more
- Locations
-
- University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
- The Kirklin Clinic at Acton Road Birmingham, Alabama, United States
- Saint Joseph's Hospital and Medical Center Phoenix, Arizona, United States
- Arizona Oncology-Deer Valley Center Phoenix, Arizona, United States
NCT01099449
- Conditions
- Chemically-Induced Disorders, Chemotherapeutic Agent Toxicity, Colonic Diseases, +18 more
- Locations
-
- Fairbanks Cancer Treatment Center at Fairbanks Memorial Hospital Fairbanks, Alaska, United States
- Kaiser Permanente - Deer Valley Antioch, California, United States
- North Bay Cancer Center Fairfield, California, United States
- Kaiser Permanente - Fremont Fremont, California, United States
NCT01372774
- Conditions
- Brain Diseases, Brain Neoplasms, Central Nervous System Diseases, +19 more
- Locations
-
- Mills - Peninsula Hospitals Burlingame, California, United States
- Los Angeles County-USC Medical Center Los Angeles, California, United States
- USC / Norris Comprehensive Cancer Center Los Angeles, California, United States
- Christiana Care Health System-Christiana Hospital Newark, Delaware, United States
NCT05040230
- Conditions
- Chemically-Induced Disorders, Immune Effector Cell Encephalopathy, Nervous System Diseases, +3 more
- Locations
-
- Uhmontpellier Montpellier, France
NCT00792142
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Chemically-Induced Disorders, +18 more
- Locations
-
- City of Hope Medical Center Duarte, California, United States
NCT01381718
- Conditions
- Brain and Central Nervous System Tumors, Central Nervous System Neoplasms, Chemically-Induced Disorders, +12 more
- Locations
-
- University of Alabama at Birmingham Birmingham, Alabama, United States
- Miller Children's Hospital Long Beach, California, United States
- Children's Hospital Los Angeles Los Angeles, California, United States
- Lucile Packard Children's Hospital Stanford University Palo Alto, California, United States
Completed
Glutamic Acid in Reducing Nerve Damage Caused by Vincristine in Young Patients With Cancer
NCT00369564
- Conditions
- Burkitt Lymphoma, Chemically-Induced Disorders, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +46 more
- Locations
-
- Lee Cancer Care of Lee Memorial Health System Fort Myers, Florida, United States
- Butterworth Hospital at Spectrum Health Grand Rapids, Michigan, United States
- Children's Hospitals and Clinics of Minnesota - Minneapolis Minneapolis, Minnesota, United States
- Hackensack University Medical Center Cancer Center Hackensack, New Jersey, United States
NCT02864030
- Conditions
- Adverse Drug Event, Breast Diseases, Breast Neoplasms, +13 more
- Locations
-
- Comprensorio sanitario di Bolzano Bolzano, Italy
- Istituti Ospitalieri di Cremona Cremona, Italy
- Azienda Ospedaliera S. Croce e Carle Cuneo, Italy
- A.O.U. Careggi Florence, Italy